放疗联合顺铂化疗治疗Ⅲ期子宫颈癌疗效分析

    Pelvic radiotherapy combined with cisplatin chemotherapy for stage Ⅲ cervical cancer

    • 摘要: 目的: 评价放疗联合顺铂综合治疗Ⅲ期子宫颈癌疗效。方法: 同期对比分析经放疗加顺铂化疗(放化组)90例和单纯放疗(单放组)74例Ⅲ期子宫颈癌患者5年生存率、局部控制率、远处转移率和并发症。结果: 5年生存率放化组60.0%,单放组43.2%(P<0.05)。局部控制率放化组57.8%,单放组37.8%(P<0.05)。远处转移率放化组35.6%,单放组33.8%(P>0.05)。放射性直肠炎:放化组11.1%,单放组10.8%(P>0.05)。放射性膀胱炎放化组6.7%,单放组6.8%(P>0.05)。无因治疗而引起的死亡发生。结论: 放射治疗联合顺铂化疗能提高Ⅲ期子宫颈癌患者局部控制率和5年生存率,未改善远处转移率,副作用能耐受。

       

      Abstract: Objective: To investigate the clinical effects of pelvic radiotherapy combined with cisplatin chemotherapy for treatment of stage Ⅲ cervical cancer.Methods: Ninety patients received pelvic radiotherapy combined with cisplatin chemotherapy while 74 patients underwent radiotherapy alone.Results: Five-year survival rates in chemo-radiotherapy group and in radiotherapy group were 60.0 and 43.2 respectively(P<0.05).Local control rates were 57.8 and 37.8 respectively(P<0.05).Distant metastasis rates were 35.6 and 33.8 respectively(P>0.05).Rectal complications were 11.1 and 10.8 respectively(P>0.05).Bladder complications were 6.7 and 6.8 respectively(P>0.05).There was no treatment mortality.Conclusions: The pelvic radiotherapy combined with cisplatin chemotherapy for treatment of stage Ⅲ cervical cancer can improve the local control rate and 5-year survival rate except the distant metastasis rate.Side effects can be alleviated.

       

    /

    返回文章
    返回